RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

Accepted Abstract is a Sub-Study in RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial and Explores the TAMP™ Therapy Platform’s Potential to Increase Local Drug Potency and Reduce Systemic ...
Yahoo Finance

RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and ...
dbta

Abstract Security’s AI-Powered Data Streaming Platform for Security is Now Generally Available

Abstract Security, crafted by category creators who redefined the cybersecurity landscape, announced the general availability (GA) of its platform designed for the future of security operations.
Nature

The outcome of abstracts presented at the United States and Canadian Academy of Pathology annual meetings

The scientific abstract program of the United States and Canadian Academy of Pathology (USCAP) annual meeting is an important forum for sharing recent advances in pathology, publishing more than 1500 ...